The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index, and 2 are not checked yet.
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Abstract
The amyloid β protein is deposited in the brains of patients with Alzheimer's disease but its pathogenic role is unknown. In culture, the amyloid β protein was neurotrophic to undifferentiated hippocampal neurons at low concentrations and neurotoxic to mature neurons at higher concentrations. In differentiated neurons, amyloid β protein caused dendritic and axonal retraction followed by neuronal death. A portion of the amyloid β protein (amino acids 25 to 35) mediated both the trophic and toxic effects and was homologous to the tachykinin neuropeptide family. The effects of the amyloid β protein were mimicked by tachykinin antagonists and completely reversed by specific tachykinin agonists. Thus, the amyloid β protein could function as a neurotrophic factor for differentiating neurons, but at high concentrations in mature neurons, as in Alzheimer's disease, could cause neuronal degeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This Aβ peptide fragment contains the biologically active portion of Aβ (Yanker et al., 1990; Takadera et al., 1993).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Yanker et al., 1990
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The establishment of polarity by hippocampal neurons in culture.
Dotti, C., Sullivan, C., & Banker, G. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-04-01454.1988 · Cited by 1,862
Glutamate neurotoxicity in cortical cell culture
Choi, D. W., Maulucci-Gedde, M., & Kriegstein, A. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00357.1987 · Cited by 1,506
Rat hippocampal neurons in dispersed cell culture.
Banker, G. A., & Cowan, W. M. (1977) · Brain Research · doi:10.1016/0006-8993(77)90594-7 · Cited by 1,110
Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., & Beyreuther, K. T. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04000.x · Cited by 1,048
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Self-citationOutgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons
Mattson, M. P., Dou, P., & Kater, S. B. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-06-02087.1988 · Cited by 557
Maggio, J. E. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000305 · Cited by 550
Research works printed but not linked: 2
- Dayhoff, M. O., Atlas of Protein Sequence and Structure 5 3: 345 (1978).
- GLENNER, G, BRANBURY REPORT 15: 137 (1983).
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Physiological levels of β-amyloid peptide promote PC12 cell proliferation
Luo, Y., Sunderland, T., Roth, G. S., & Wolozin, B. L. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13087-1 · Cited by 49
Sigurdsson, E. M., Lorens, S. A., Hejna, M. J., Dong, X.-W., & Lee, J. M. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00169-8 · Cited by 49
Papastoitsis, G., Siman, R., Scott, R. W., & Abraham, C. R. (1994) · Biochemistry · doi:10.1021/bi00167a025 · Cited by 49
Colombo, J. A., Reisin, H. D., Jones, M., & Bentham, C. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.024 · Cited by 48
Tohda, C., Ichimura, M., Bai, Y., Tanaka, K., Zhu, S., & Komatsu, K. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08046fp · Cited by 48
McAllister, B. B., Lacoursiere, S. G., Sutherland, R. J., & Mohajerani, M. H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.026 · Cited by 48
Memory Deficits in Aging and Neurological Diseases
Khan, Z. U., Martín‐Montañez, E., Navarro‐Lobato, I., & Muly, E. C. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00001-5 · Cited by 48
Pannaccione, A., Secondo, A., Scorziello, A., Calı̀, G., Taglialatela, M., & Annunziato, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03075.x · Cited by 48
Sáez, E. T., Pehar, M., Vargas, M. R., Barbeito, L., & Maccioni, R. B. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20996 · Cited by 48
Shah, P., Lal, N., Leung, E., Traul, D., Gonzalo‐Ruiz, A., & Geula, C. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090937 · Cited by 48
APP-collagen interaction is mediated by a heparin bridge mechanism
Breen, K. C. (1992) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159964 · Cited by 48
Tau protein and neurodegeneration
Kosik, K. S. (1990) · Molecular Neurobiology · doi:10.1007/bf02780339 · Cited by 48
Kozlowski, M. R., Spanoyannis, A., Manly, S., Fidel, S., & Neve, R. L. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01679.1992 · Cited by 48
Pieri, M., Amadoro, G., Carunchio, I., Ciotti, M. T., Quaresima, S., Florenzano, F., Calissano, P., Possenti, R., Zona, C., & Severini, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.029 · Cited by 47
Sehgal, S. A., Hammad, M. A., Tahir, R. A., Akram, H. N., & Ahmad, F. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180315142137 · Cited by 47
Oxidation destabilizes toxic amyloid beta peptide aggregation
Razzokov, J., Yusupov, M., & Bogaerts, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41931-6 · Cited by 47
Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease
Martinez, J. L., Zammit, M. D., West, N. R., Christian, B. T., & Bhattacharyya, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.703876 · Cited by 47
Cho, J., Kim, H. M., Ryu, J., Jeong, Y. S., Lee, Y. S., & Jin, C. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.455 · Cited by 47
Gong, Q., Pan, L., Liu, X., Wang, Q., Huang, H., & Zhu, Y. Z. (2010) · Amino Acids · doi:10.1007/s00726-010-0685-1 · Cited by 47
ReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease
Veurink, G., Fuller, S. J., Atwood, C., & Martins, R. N. (2003) · Annals of Human Biology · doi:10.1080/03014460310001620144 · Cited by 47
Stereochemical specificity of Alzheimer's disease ?-peptide assembly
Esler, W. P., Stimson, E. R., Fishman, J. B., Ghilardi, J. R., Vinters, H. V., Mantyh, P. W., & Maggio, J. E. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(199905)49:6 · Cited by 47
Liu, Y. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00003-2 · Cited by 47
Toide, K., Fujiwara, T., Iwamoto, Y., Shinoda, M., Okamiya, K., & Kato, T. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168640 · Cited by 47
Tanaka, S., Liu, L., Kimura, J., Shiojiri, S., Takahashi, Y., Kitaguchi, N., Nakamura, S., & Ueda, K. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90122-r · Cited by 47
Boland, K. A., Manias, K., & Perlmutter, D. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28022 · Cited by 47
Mosconi, L., Glodzik, L., Mistur, R., McHugh, P., Rich, K. E., Javier, E., Williams, S., Pirraglia, E., De Santi, S., Mehta, P. D., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.011 · Cited by 46
Benzing, W. C., Ikonomovic, M. D., Brady, D. R., Mufson, E. J., & Armstrong, D. M. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903340203 · Cited by 46
Ferrera, P., Mercado-Gómez, O. F., Silva-Aguilar, M., Valverde, M., & Arias, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9623-y · Cited by 46
Isono, T., Yamashita, N., Obara, M., Araki, T., Nakamura, F., Kamiya, Y., Alkam, T., Nitta, A., Nabeshima, T., Mikoshiba, K., et al. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.08.005 · Cited by 46
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
Wells, C., Brennan, S. E., Keon, M., & Saksena, N. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00271 · Cited by 46
Aβ25–35 Suppresses Mitochondrial Biogenesis in Primary Hippocampal Neurons
Dong, W., Wang, F., Guo, W.-Q., Zheng, X., Chen, Y., Zhang, W., & Shi, H. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0222-6 · Cited by 46
Rösler, N., Wichart, I., & Jellinger, K. A. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170091 · Cited by 46
The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease
Ehrenstein, G., Galdzicki, Z., & Lange, G. D. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78160-8 · Cited by 46
Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death
Jin, L., Hua, D. H., Shie, F., Maezawa, I., Sopher, B. L., & Martin, G. M. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0011-9 · Cited by 46
Lau, T., Gehman, J. D., Wade, J. D., Perez, K. A., Masters, C. L., Barnham, K. J., & Separovic, F. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.004 · Cited by 46
Activation of Human Macrophages by Amyloid-β Is Attenuated by Astrocytes
Smits, H. A., van Beelen, A. J., Vos, N., Rijsmus, A., van der Bruggen, T., Verhoef, J., Muiswinkel, F. L. V., & Nottet, H. S. L. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6869 · Cited by 46
Yagami, T., Ueda, K., Asakura, K., Sakaeda, T., Kuroda, T., Hata, S., Kambayashi, Y., & Fujimoto, M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704261 · Cited by 46
β-Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield
Miguel-Hidalgo, J. J., & Cacabelos, R. (1998) · Acta Neuropathologica · doi:10.1007/s004010050825 · Cited by 46
Dudás, B., Cornelli, U., Lee, J. M., Hejna, M. J., Walzer, M., Lorens, S. A., Mervis, R. F., Fareed, J., & Hanin, I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00255-x · Cited by 46
Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro
Pike, C. J., & Cotman, C. W. (1995) · Brain Research · doi:10.1016/0006-8993(94)01354-k · Cited by 46
Physiological levels of β-amyloid increase tyrosine phosphorylation and cytosolic calcium
Luo, Y. Q., Hirashima, N., Li, Y. H., Alkon, D. L., Sunderland, T., Etcheberrigaray, R., & Wolozin, B. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00282-u · Cited by 46
Mapping biochemistry to metabolism
Mega, M. S., Chu, T., Mazziotta, J. C., Trivedi, K. H., Thompson, P. M., Shah, A. A., Cole, G. M., Frautschy, S. A., & Toga, A. W. (1999) · Neuroreport · doi:10.1097/00001756-199909290-00007 · Cited by 46
Characterization of 8‐Epiprostaglandin F2α as aMarker of Amyloid β‐Peptide‐Induced Oxidative Damage
Mark, R. J., Fuson, K. S., & May, P. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721146.x · Cited by 46
Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Liu, Y., Li, Z., Hu, H., Xu, S., Chang, Q., Liao, Y., Pan, R., & Liu, X. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.010 · Cited by 45
Ursolic acid attenuates beta-amyloid-induced memory impairment in mice
Liang, W., Zhao, X., Feng, J., Song, F., & Pan, Y. (2016) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20160065 · Cited by 45
The cAMP-specific phosphodiesterase 4B mediates Aβ-induced microglial activation
Sebastiani, G., Morissette, C., Lagacé, C., Boulé, M., Ouellette, M., McLaughlin, R. W., Lacombe, D., Gervais, F., & Tremblay, P. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.024 · Cited by 45
Examination of potential mechanisms of amyloid-induced defects in neuronal transport
Shah, S. B., Nolan, R. L., Davis, E., Stokin, G. B., Niesman, I. R., Canto, I., Glabe, C. G., & Goldstein, L. S. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.016 · Cited by 45
Benzing, W. C., Mufson, E. J., & Armstrong, D. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90145-d · Cited by 45
Opioid receptor density changes in Alzheimer amygdala and putamen
Barg, J., Belcheva, M. M., Rowiński, J., Ho, A., Burke, W. J., Chung, H. D., Schmidt, C. A., & Coscia, C. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91155-l · Cited by 45
Harkany, T., O'Mahony, S., Keijser, J. N., Kelly, J. P., Kónya, C., Borostyánköi, Z., Görcs, T. J., Zarándi, M., Penke, B., Leonard, B. E., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0398 · Cited by 45
Freir, D. B., & Herron, C. E. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00996.2002 · Cited by 45
Taglialatela, G., Robinson, R. C., & Perez-Polo, J. R. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970115)47:2 · Cited by 170
Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer’s disease
Wirths, O., & Zampar, S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702972 · Cited by 44
The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy
Peña‐Ortega, F., Gutiérrez-Lerma, A. I., Quiroz‐Baez, R., & Arias, C. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359531 · Cited by 45
Chang, C., Liu, Y., Lin, H., Hsu, C., Cheng, B., Liu, W., Lin, M., Hsu, S.-F., Chang, L., & Lin, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9623-2 · Cited by 44
Mirzaie, Z., Ansari, M., Kordestani, S. S., Habibi-Rezaei, M., & Mozafari, M. (2019) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1751 · Cited by 44
Dehydroevodiamine attenuates β-amyloid peptide-induced amnesia in mice
Wang, H., Chou, C., Liao, J., & Chen, C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00913-4 · Cited by 44
Genetic Alterations of the BRI2 gene: Familial British and Danish Dementias
J, G., A, R., Y, T., T, L., M, B.-M., H, B., G, P., J, H., R, L., T, R., et al. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00563.x · Cited by 44
Pharmacological Enhancement of Neuronal Survival
Calabrese, E. J. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440801981973 · Cited by 44
Muralidharan, P., Kumar, V., & Balamurugan, G. (2009) · Phytotherapy Research · doi:10.1002/ptr.2922 · Cited by 44
Lin, K., Chang, R. C., Suen, K., So, K., & Hugon, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03245.x · Cited by 44
Structure‐based subsite specificity mapping of human cathepsin D using statine‐based inhibitors
Majer, P., Collins, J., Gulnik, S., & Erickson, J. W. (1997) · Protein Science · doi:10.1002/pro.5560060710 · Cited by 44
Pavı́a, J., CEBALLOS, M. L. D., & de la Cuesta, F. S. (1998) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00975.x · Cited by 44
Takenouchi, T., & Munekata, E. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00235-x · Cited by 44
Possible Role(s) of Neurokinins in CNS Development and Neurodegenerative or Other Disorders
Raffa, R. B. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00070-5 · Cited by 44
Walter, M. F., Mason, P. E., & Mason, R. P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6547 · Cited by 44
β-Amyloid(25–35) induces the production of interleukin-8 from human monocytes
Meda, L., Bonaiuto, C., Szendrei, G. I., Ceska, M., Rossi, F., & Cassatella, M. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00021-s · Cited by 44
Hao, S., Li, X., Han, A., Yang, Y., Fang, G., Liu, J., & Wang, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00469 · Cited by 43
Tikhonova, M. A., Shoeva, O. Y., Tenditnik, M. V., Ovsyukova, M. V., Akopyan, A. A., Dubrovina, N. I., Amstislavskaya, T. G., & Хлесткина, Е. К. (2020) · Nutrients · doi:10.3390/nu12123877 · Cited by 43
An Update on the Amyloid Hypothesis
Eckman, C. B., & Eckman, E. A. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.007 · Cited by 43
Lee, A. Y., Hwang, B. R., Lee, M. H., Lee, S., & Cho, E. J. (2016) · Nutrition Research and Practice · doi:10.4162/nrp.2016.10.3.274 · Cited by 43
Trubetskaya, V. V., Stepanichev, M. Y., Onufriev, M. V., Лазарева, Н. А., Markevich, V. A., & Gulyaeva, N. V. (2003) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1021761310435 · Cited by 43
The role of Bax in glutamate‐induced nerve cell death
Dargusch, R., Piasecki, D. P., Tan, S., Liu, Y., & Schubert, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00035.x · Cited by 43
Yang, S., Kwon, B., Gho, Y. S., & Chae, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02993.x · Cited by 43
Amyloid precursor protein is enriched in radial glia: Implications for neuronal development
Trapp, B. D., & Hauer, P. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370413 · Cited by 43
Vogt, B. A., Crino, P. B., & Vogt, L. J. (1992) · Cerebral Cortex · doi:10.1093/cercor/2.6.526 · Cited by 43
The legacy of nanotechnology: Revolution and prospects in neurosurgery
Khawaja, A. M. (2011) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.002 · Cited by 42
Protective Effect of Bajijiasu Against β-Amyloid-Induced Neurotoxicity in PC12 Cells
Chen, D., Zhang, P., Lin, L., Shuai, O., He-Ming, Z., Liu, S., & Wang, J.-Y. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9950-7 · Cited by 42
Gospodarska, E., Kupniewska-Kozak, A., Goch, G., & Dadlez, M. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.02.011 · Cited by 42
Kuboyama, T., Hirotsu, K., Arai, T., Yamasaki, H., & Tohda, C. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00805 · Cited by 42
Raut, S., Patel, R., & Al-Ahmad, A. J. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00235-y · Cited by 42
The Inside-Out Amyloid Hypothesis and Synapse Pathology in Alzheimer's Disease
Gouras, G. K., Willén, K. I., & Faideau, M. (2013) · Neurodegenerative Diseases · doi:10.1159/000354776 · Cited by 42
Awale, S., Tohda, C., Tezuka, Y., Miyazaki, M., & Kadota, S. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep149 · Cited by 42
RetractedLoss of endophilin-B1 exacerbates Alzheimer’s disease pathology
Wang, D. B., Kinoshita, Y., Kinoshita, C., Uo, T., Sopher, B. L., Cudaback, E., Keene, C. D., Bilousova, T. V., Gylys, K. H., Case, A., et al. (2015) · Brain · doi:10.1093/brain/awv128 · Cited by 42
Harkany, T., Penke, B., & Luiten, P. G. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06389.x · Cited by 42
Amyloid β-peptide(1–40)-mediated oxidative stress in cultured hippocampal neurons
Aksenov, M. Y., Aksenova, M. V., Markesbery, W. R., & Butterfield, D. A. (1998) · Journal of Molecular Neuroscience · doi:10.1007/bf02761773 · Cited by 42
Muñoz, D. G., & Wang, D. (1992) · PubMed · Cited by 42
Korotzer, A. R., Whittemore, E. R., & Cotman, C. W. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90006-3 · Cited by 42
Ueda, K., Yagami, T., Kageyama, H., & Kawasaki, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12288-5 · Cited by 42
Amyloid β-protein Induces Necrotic Cell Death Mediated by ICE Cascade in PC12 Cells
Suzuki, A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3639 · Cited by 42
Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade
Whitson, J. S., & Appel, S. H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80002-9 · Cited by 41
Mutations Alter the Geometry and Mechanical Properties of Alzheimer’s Aβ(1−40) Amyloid Fibrils
Paparcone, R., Pires, M. A., & Buehler, M. J. (2010) · Biochemistry · doi:10.1021/bi100953t · Cited by 41
All- d -Enantiomer of β-Amyloid Peptide Forms Ion Channels in Lipid Bilayers
Capone, R. F., Jang, H., Kotler, S. A., Connelly, L. S., Arce, F. T., Ramachandran, S., Kagan, B. L., Nussinov, R., & Lal, R. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct200885r · Cited by 41
Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K⁄Akt pathway
Sun, Z., Yang, H., Wang, Z., Jing, P., Zhen, H., & Sheng-Di, C. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-7 · Cited by 41
Yamin, R., Bagchi, S., Hildebrant, R., Scaloni, A., Widom, R. L., & Abraham, C. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04251.x · Cited by 41
A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly
Chouraki, V. A., de Bruijn, R. F. A. G., Chapuis, J., Bis, J. C., Reitz, C., Schraen‐Maschke, S., Ibrahim‐Verbaas, C. A., Grenier‐Boley, B., Delay, C., Rogers, R. S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.185 · Cited by 41
Cellular uptake of the prion protein fragment PrP106-126 in vitro
McHattie, S., Brown, D. R., & Bird, M. M. (1999) · Journal of Neurocytology · doi:10.1023/a:1007028323666 · Cited by 41
What is the dominant aβ species in human brain tissue? A review
Gregory, G. C., & Halliday, G. M. (2005) · Neurotoxicity Research · doi:10.1007/bf03033774 · Cited by 41
Misiti, F., Sampaolese, B., Mezzogori, D., Orsini, F., Pezzotti, M., Giardina, B., & Clementi, M. E. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.07.012 · Cited by 41
Metadata
- Authors
- Yankner, B. A., Duffy, L. K., & Kirschner, D. A.
- Affiliations
- Boston Children's Hospital (US)
- University of Alaska Fairbanks (US)
- Venue
- Science
- Published
- 1990-10-12
- Volume
- 250
- Issue
- 4978
- Pages
- 279-282
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2059214757
- Cited by
- 1,975
- References
- 31
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 15 · 2023: 22 · 2022: 14 · 2021: 29 · 2020: 19 · 2019: 29 · 2018: 32 · 2017: 27 · 2016: 37 · 2015: 44 · 2014: 46 · 2013: 40 · 2012: 40
- FWCI
- 64.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG08572, R01AG008572)
- National Institute of Neurological Disorders and Stroke (NS01240, K08NS001240)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, Alzheimer's disease, neurotoxicity, neurotrophic effects, tachykinin antagonists, hippocampal neurons, neuronal differentiation, neuronal cell death, dendritic retraction, axonal retraction, neurotrophic factors
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Embryo, Mammalian, Hippocampus, Molecular Sequence Data, Neurons, Neurotoxins, Peptide Fragments, Tachykinins, Amyloid beta-Peptides, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review